Assembly Biosciences (ASMB) Capital Expenditures (2011 - 2026)

Assembly Biosciences' Capital Expenditures history runs 16 years deep, the most recent figure standing at $19000.0 for Q1 2026.

• In Q1 2026, Capital Expenditures changed N/A year-over-year to $19000.0; the TTM figure through Mar 2026 stood at $85000.0 (up 507.14% YoY), while the FY2025 annual figure was $66000.0, up 135.71% from the prior year.
• Capital Expenditures was $19000.0 for Q1 2026 at Assembly Biosciences, down from $24000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $136000.0 in Q3 2023 to a low of $14000.0 in Q1 2024.
• Historically, Capital Expenditures has averaged $52222.2 across 5 years, with a median of $42000.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures jumped 33.33% in 2023, then slumped 70.83% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $102000.0 in 2022, then sank by 30.39% to $71000.0 in 2023, then plunged by 80.28% to $14000.0 in 2024, then jumped by 71.43% to $24000.0 in 2025, then fell by 20.83% to $19000.0 in 2026.
• The last three Capital Expenditures figures came in at $19000.0 (Q1 2026), $24000.0 (Q4 2025), and $42000.0 (Q3 2025), per Business Quant data.